News | February 08, 2010

Philips Highlights Hybrid ORs, Cardiac Imaging, Testing at ACC

At the American College of Cardiology (ACC) 2010, Philips Healthcare will focus on the full spectrum of cardiology care – from diagnosis and treatment to disease management and home monitoring to enhance patient care. Philips is the imaging systems sponsor of the ACC’s Hybrid OR Suite exhibit, a combination cath lab and operating room.

Attendees can experience how Philips imaging equipment and solutions and its partnerships with leading OR equipment makers can help create an optimally designed hybrid.

New at ACC will be Cardiac Explorer, a package that helps in determining heart parameters from MR data into a comprehensive clinical report. It uses a task-guided approach where users are led step-by-step through successive tasks required to generate a clinical report. Cardiac analysis includes completely automated segmentation of the endo and epicardial boundaries, and a full report is generated with a detailed overview of global and regional heart function and wall motion parameters, including diastolic function.

The company will showcase the clinical advancements the Brilliance iCT, including new software. The newest program is a coronary plaque analysis application, which enables clinicians to gain a better understanding of the distribution and composition of plaque inside coronary vessels. This evaluation helps identify sites that are dangerous and which are small in size, but may become dangerous if not treated.

The PageWriter TC series of electrocardiographs (ECGs) combines easy operation with interpretations. The systems offer a suite of STEMI diagnostic aids, enabled by the advanced DXL ECG Algorithm, to help quickly identify when a patient requires immediate physician attention. When used with the TraceMasterVue ECG management system, the clinical user also can have immediate access to previous ECG records at the point of decision.

Announced in January 2010, Philips and bioMérieux have reached an agreement to jointly develop fully automated handheld diagnostic testing solutions for hospital use that can be deployed at the point-of-care. In critical-care settings, such as emergency departments, there is a persistent clinical need for diagnostic solutions that enable fast and accurate patient triage, such diagnosing acute coronary syndromes. The automated handheld testing devices that will be developed jointly by Philips and bioMérieux will be immunoassay-based and employ Philips’ new Magnotech biosensor platform. They are intended to assist clinicians in time-critical decision-making by reducing delays involved in laboratory-based testing.

From Philips Respironics, the Alice PDx Portable Recording System is a diagnostic recording device with advanced features intended for obstructive sleep apnea (OSA) diagnosis or assessment of cardio-respiratory sleep disorders. The device is convenient for patients who are uncomfortable with, or have limited access to, a sleep lab facility. The Good Study Indicator incorporated into the device helps clinicians determine the validity of the data that has been collected overnight. Remote testing and data verification both help clinicians avoid the costs associated with retesting.

The Philips Healthcare booth is 1343. Its hybrid OR suite will be located in booth 2744.

Related Content

Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Key Patient Preparations for a CT Scan
News | Computed Tomography (CT) | September 05, 2018
The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should...
Videos | Computed Tomography (CT) | July 25, 2018
A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associat
Videos | Computed Tomography (CT) | July 23, 2018
Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiova
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
James Min Named Editor-in-Chief of Journal of Cardiovascular Computed Tomography
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.
Overlay Init